Executive Director of MOLSID Showcases Product Pipeline at ESCMID GLOBAL Conference
It was a pleasure for MOLSID, represented by its Executive Director Younes Lazrak, to present our product pipeline at this year’s ESCMID GLOBAL. Many thanks go to BEAM ALLIANCE for the invitation to the pipeline corner and to Till Bachman for organising the session. Younes Lazrak and our CSA Jens Hasserodt truly enjoyed meeting up […]
Molsid develop the first truly rapid test for AMR in primary clinical samples
How about you? Do you contribute to the containment of Antimicrobial Resistance that threats us all? We at Molsid do our part. We develop the first truly rapid test for AMR in primary clinical samples. That’s why we are an official contender for the Longitude Prize that calls for just such a test that’s rapid first and foremost, […]
DRIBA project
« DRIBA », project by VETOPHAGE, Molsid and École normale supérieure de Lyon, funded by Région Auvergne-Rhône-Alpes with the support of Bpifrance, will develop the first kit for the detection of the pathogenic bacterium S.aureus and of the presence of antibiotic resistance for bovine mastitis. Bovine mastitis, a bacterial infection of cows’ udders, affects 40% of the 3.7 million dairy cows in France each […]
Molsid has been accepted by the Longitude Prize for AMR as a competing team
We are proud to announce that Molsid has been accepted by the Longitude Prize for AMR as a competing team. This is a great honour as it shows that we fulfil the stringent criteria that a team needs to fulfil in order to enter the race. We look forward to present to the jury our PYTHIA kit & device […]
Molsid new corporate website
MOLSID is happy to announce the launch of its new corporate website. Visit us at www.molsid.com and learn more about our PYTHIA project. Thank you to Abyxo Team for your great work!
PYTHIA – Preclinical Trials – Exceptional Results – 08/06/2022
Unprecedented detection sensitivity and quantitation of most enzyme activities allowed us to even determine bacterial counts as low as 1.000 to 10.000 bacteria/mL.
Molsid nominated for the 2019 Innovation Awards
Linked to Molsid participation to the Lab’Startup Village at the next Forum Labo exhibition in Paris, the company has been nominated for the 2019 Innovation Awards with a possibility to win the French Startup Trophy. The award ceremony will take place on Tuesday March 26. >> Read more
PIA4 – AMI GRAND DEFI – LAUREATS – 08/11/2021
Molsid est fière de faire partie des premiers lauréats de l’appel à manifestation d’intérêt (AMI) du Grand Défi (PIA4) « Nouvelles biothérapies et outils de production » en tant que partenaire du projet « SCANBioM2 » dont bioMérieux est le coordinateur. Le 4è PIA (PIA4) est doté de 20 Md€ d’engagements sur la période 2021-2025, dont 11 Md€ contribueront à […]
ISO 9001:2015 certification
We at Molsid are proud to announce the ISO 9001:2015 certification of our management system, as approved by DEKRA. This certification has been achieved through stringent adherence to operating standards by our team. It covers the development, production and commercialisation of our fluorogenic molecular probes and kits. We constantly aim at improving our products and […]
Molsid has been awarded the European SEAL OF EXCELLENCE
The Molsid Team has recently presented a major innovative R&D project to the European Commission which has been noted 14.1 out of 15 points. The result was Molsid being awarded the European « SEAL OF EXCELLENCE ».
